GlassScriptPhysician profile
Wendell C Heidinger
NPI 1326184607
$4,171.99
in general payments reported to CMS, 2019-2025
33 companies · $828 in 2025
The $828 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $381 · 2021: $849 · 2022: $659 · 2023: $595 · 2024: $751 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,158 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,157.70 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $666.11 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $399.29 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $376.86 | 2020-2025 | Mounjaro, Jardiance, Emgality |
| Amgen INC. | $336.27 | 2019-2025 | Repatha, Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $303.91 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $277.93 | 2020-2023 | Xarelto |
| Glaxosmithkline, LLC. | $269.03 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $253.80 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $204.04 | 2022-2025 | |
| Amarin Pharma, INC. | $118.39 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $112.66 | 2022-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $107.66 | 2020-2021 | |
| Allergan, INC. | $98.73 | 2019-2020 | |
| Exact Sciences Corporation | $83.50 | 2023-2025 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $79.72 | 2020-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $64.13 | 2021 | |
| Ascendis Pharma Endocrinology INC | $48.26 | 2025 | Yorvipath |
| Axsome Therapeutics, INC. | $38.54 | 2023 | Auvelity |
| Aimmune Therapeutics, INC. | $37.80 | 2025 | Zenpep |
| Baxter Healthcare | $35.47 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $33.23 | 2021-2022 | |
| Averitas Pharma INC. | $24.39 | 2025 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $23.81 | 2025 | Zoryve |
| Tempus Ai, INC | $22.23 | 2024 | |
| Astellas Pharma US INC | $22.19 | 2023 | Veozah |
| Phathom Pharmaceuticals, INC. | $21.46 | 2024 | Voquezna |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.49 | 2025 | Jardiance |
| Biohaven Pharmaceuticals, INC. | $20.00 | 2021 | |
| Xeris Pharmaceuticals, INC. | $18.14 | 2025 | Gvoke Hypopen |
| Hologic Sales and Service, LLC | $15.33 | 2020 | |
| Dexcom, INC. | $14.38 | 2022 | |
| Acadia Pharmaceuticals INC | $12.17 | 2019 | |
| Daiichi Sankyo INC. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendell Heidinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.